Status:

ACTIVE_NOT_RECRUITING

Pulmonary Arterial Hypertension Improvement With Nutrition and Exercise (PHINE)

Lead Sponsor:

The Cleveland Clinic

Collaborating Sponsors:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Pulmonary Arterial Hypertension

Insulin Resistance

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

The purpose of this study is to investigate the extent to which diet and exercise may improve PAH through the modulation of insulin sensitivity. The central hypothesis is that dysregulated glucose met...

Detailed Description

Pulmonary arterial hypertension (PAH) leads to premature death as a consequence of increased pulmonary vascular resistance and right heart failure. PAH-targeted therapies developed over the past 20 ye...

Eligibility Criteria

Inclusion

  • Age range between 18-75 years old
  • Group 1 PAH, including idiopathic, heritable, drugs and toxin induced, and PAH associated with connective tissue disease, HIV infection and congenital heart disease
  • NYHA Class II or III
  • ≥ 1 PAH-targeted therapy with a stable dose for ≥ 2 months
  • Stable dose of diuretics and rate of supplemental oxygen for the preceding 2 months

Exclusion

  • Decompensated Right Heart Failure
  • NYHA Class IV
  • Syncope within the previous 3 months
  • Cardiac Arrhythmia (except for controlled atrial fibrillation or flutter)
  • Baseline supplemental O2 \> 4 LPM
  • Portal Hypertension
  • Pulmonary hypertension due to Lung Disease and Hypoxia
  • Pulmonary Hypertension due to Left Heart Disease
  • Chronic Thromboembolic Pulmonary Hypertension
  • Pulmonary Hypertension associated with systemic diseases such as hematological disorders and sarcoidosis
  • Type 2 Diabetes
  • Evidence of cardiac ischemia on a graded exercise test

Key Trial Info

Start Date :

September 27 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 30 2026

Estimated Enrollment :

34 Patients enrolled

Trial Details

Trial ID

NCT03288025

Start Date

September 27 2017

End Date

June 30 2026

Last Update

September 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cleveland Clinic Foundation

Cleveland, Ohio, United States, 44195

Pulmonary Arterial Hypertension Improvement With Nutrition and Exercise (PHINE) | DecenTrialz